Greenwich Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Buy
4,509
+93
+2% +$21.7K 0.05% 148
2025
Q4
$914K Buy
4,416
+378
+9% +$74.7K 0.04% 153
2025
Q3
$749K Buy
4,038
+1,141
+39% +$195K 0.04% 169
2025
Q2
$442K Sell
2,897
-263
-8% -$40.4K 0.02% 187
2025
Q1
$524K Sell
3,160
-983
-24% -$154K 0.04% 157
2024
Q4
$599K Buy
4,143
+934
+29% +$145K 0.04% 152
2024
Q3
$520K Sell
3,209
-58
-2% -$9.24K 0.04% 168
2024
Q2
$478K Buy
3,267
+68
+2% +$10.1K 0.03% 164
2024
Q1
$506K Sell
3,199
-145
-4% -$23.1K 0.04% 161
2023
Q4
$524K Sell
3,344
-22
-0.7% -$3.37K 0.05% 156
2023
Q3
$524K Sell
3,366
-802
-19% -$132K 0.06% 146
2023
Q2
$690K Sell
4,168
-93
-2% -$15K 0.07% 136
2023
Q1
$660K Buy
4,261
+8
+0.2% +$1.29K 0.07% 141
2022
Q4
$751K Sell
4,253
-92
-2% -$15.9K 0.08% 125
2022
Q3
$710K Buy
4,345
+187
+4% +$31.6K 0.08% 128
2022
Q2
$738K Buy
4,158
+154
+4% +$27.4K 0.1% 129
2022
Q1
$710K Sell
4,004
-114
-3% -$19.4K 0.07% 137
2021
Q4
$704K Buy
4,118
+249
+6% +$40.8K 0.06% 137
2021
Q3
$625K Buy
3,869
+1,488
+62% +$254K 0.05% 145
2021
Q2
$392K Buy
2,381
+169
+8% +$28K 0.03% 162
2021
Q1
$364K Buy
2,212
+184
+9% +$29.8K 0.03% 153
2020
Q4
$319K Sell
2,028
-561
-22% -$82.8K 0.03% 150
2020
Q3
$385K Buy
2,589
+226
+10% +$33.4K 0.07% 134
2020
Q2
$332K Buy
2,363
+421
+22% +$61.4K 0.06% 135
2020
Q1
$255K Sell
1,942
-446
-19% -$63.3K 0.05% 142
2019
Q4
$348K Buy
2,388
+46
+2% +$6.24K 0.07% 146
2019
Q3
$303K Sell
2,342
-1,483
-39% -$195K 0.06% 149
2019
Q2
$533K Buy
3,825
+280
+8% +$38.8K 0.09% 117
2019
Q1
$496K Sell
3,545
-2
-0.1% -$268 0.09% 117
2018
Q4
$458K Sell
3,547
-207
-6% -$28.9K 0.09% 115
2018
Q3
$519K Buy
3,754
+399
+12% +$53K 0.09% 117
2018
Q2
$407K Sell
3,355
-377
-10% -$47K 0.07% 128
2018
Q1
$478K Sell
3,732
-32
-0.9% -$4.33K 0.08% 114
2017
Q4
$526K Sell
3,764
-288
-7% -$40.1K 0.09% 114
2017
Q3
$527K Sell
4,052
-2
-0% -$265 0.09% 111
2017
Q2
$536K Sell
4,054
-339
-8% -$43.2K 0.09% 109
2017
Q1
$547K Buy
4,393
+1,653
+60% +$197K 0.07% 103
2016
Q4
$316K Buy
2,740
+246
+10% +$28.4K 0.04% 152
2016
Q3
$295K Hold
2,494
0.05% 158
2016
Q2
$303K Buy
2,494
+27
+1% +$3.07K 0.07% 149
2016
Q1
$267K Buy
2,467
+357
+17% +$37K 0.07% 156
2015
Q4
$217K Buy
+2,110
New +$212K 0.05% 138
2015
Q3
Sell
-2,121
Closed -$207K 175
2015
Q2
$207K Sell
2,121
-22
-1% -$2.2K 0.03% 163
2015
Q1
$216K Sell
2,143
-711
-25% -$72.3K 0.02% 160
2014
Q4
$298K Sell
2,854
-45
-2% -$4.74K 0.02% 152
2014
Q3
$309K Buy
2,899
+34
+1% +$3.53K 0.02% 151
2014
Q2
$300K Hold
2,865
0.02% 137
2014
Q1
$281K Sell
2,865
-550
-16% -$51K 0.02% 136
2013
Q4
$313K Hold
3,415
0.03% 137
2013
Q3
$296K Hold
3,415
0.02% 135
2013
Q2
$293K Buy
+3,415
New +$290K 0.02% 124

Other funds holding JNJ

Greenwich Wealth Management's JNJ Position: Q1 2026 in Review

Greenwich Wealth Management increased its Johnson & Johnson (JNJ) stake by 2.1% in Q1 2026, buying an estimated $21.7K and bringing the position to 4,509 shares worth $1.1M. The position accounts for 0.05% of the portfolio, ranked #148.

Greenwich Wealth Management first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Greenwich Wealth Management held 4,509 shares of Johnson & Johnson worth $1.1M as of Q1 2026.
  • Greenwich Wealth Management bought 93 Johnson & Johnson shares in Q1 2026, an estimated $21.7K.
  • Johnson & Johnson made up 0.05% of Greenwich Wealth Management's portfolio in Q1 2026, its #148 holding.
  • Greenwich Wealth Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.